Invention Grant
![[6,6] fused bicyclic HDAC8 inhibitors](/docs/US/2022-08-16/US11414392B2/abs.jpg.600x600.jpg)
- Patent Title: [6,6] fused bicyclic HDAC8 inhibitors
-
Application No.: US17066385Application Date: 2020-10-08
-
Publication No.: US11414392B2Publication Date: 2022-08-16
- Inventor: Xiaozhang Zheng , Pui Yee Ng , Jennifer R. Thomason , Mary-Margaret Zablocki , Bingsong Han , Nicholas Barczak , Cuixian Liu , Aleksandra Rudnitskaya , David R. Lancia, Jr. , Kenneth W. Bair
- Applicant: Valo Health, Inc.
- Applicant Address: US MA Boston
- Assignee: Valo Health, Inc.
- Current Assignee: Valo Health, Inc.
- Current Assignee Address: US MA Boston
- Agency: Choate, Hall & Stewart LLP
- Agent John P. Rearick; Michael A. Shinall
- Main IPC: C07D265/36
- IPC: C07D265/36 ; C07D413/12 ; C07D413/06 ; C07D401/04 ; C07D279/16 ; C07D491/107 ; C07D413/10 ; C07D471/04 ; C07D417/06 ; C07D513/04 ; C07D487/04 ; C07D265/34 ; C07D279/14
![[6,6] fused bicyclic HDAC8 inhibitors](/abs-image/US/2022/08/16/US11414392B2/abs.jpg.150x150.jpg)
Abstract:
The present invention is directed to compounds of Formula I: and pharmaceutically acceptable salts, prodrugs, solvates, hydrates, tautomers, or isomers or thereof, wherein R1, R2, R2′, L, X, W, Y1, Y2, Y3, and Y4 are described herein.
Public/Granted literature
- US20210139439A1 [6,6] FUSED BICYCLIC HDAC8 INHIBITORS Public/Granted day:2021-05-13
Information query
